Contracts Finder · Award
Bleeding Disorders including Haemophilia B
A public procurement published by NHS England via Contracts Finder.
- £500m
- Award value
- £250m
- Tender value
- 8
- Suppliers
- 16
- Awards
- 2
- Notices
- Award
- Stage
Overview
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. Period of framework agreement: 1 July 2022 to 30 June 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement including extension options will be no more than 48 months
Key details
- Buyer
- NHS England
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 33141530 — Blood coagulants
- Currency
- GBP
- Total award value
- £500,000,000
- Tender value
- £250,000,000
- First published
- 5 Jul 2022
- Last updated
- 20 Jul 2022
Awards
16 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Pfizer Ltd | 00526209 | 14 Jun 2022 | active | £250m |
| Octapharma Limited | 02372699 | 14 Jun 2022 | active | £250m |
| CSL Behring UK Ltd | 01622483 | 14 Jun 2022 | active | £250m |
| Novo Nordisk | 01118740 | 14 Jun 2022 | active | £250m |
| Bio Products Laboratory Ltd | 07343036 | 14 Jun 2022 | active | £250m |
| Takeda UK Ltd | 03362860 | 14 Jun 2022 | active | £250m |
| Sobi (Swedish Orphan Biovitrum Ltd) | — | 14 Jun 2022 | active | £250m |
| LFB | — | 14 Jun 2022 | active | £250m |
| Pfizer Ltd | 00526209 | 14 Jun 2022 | active | £250m |
| Octapharma Limited | 02372699 | 14 Jun 2022 | active | £250m |
| CSL Behring UK Ltd | 01622483 | 14 Jun 2022 | active | £250m |
| Novo Nordisk | 01118740 | 14 Jun 2022 | active | £250m |
| Bio Products Laboratory Ltd | 07343036 | 14 Jun 2022 | active | £250m |
| Takeda UK Ltd | 03362860 | 14 Jun 2022 | active | £250m |
| Sobi (Swedish Orphan Biovitrum Ltd) | — | 14 Jun 2022 | active | £250m |
| LFB | — | 14 Jun 2022 | active | £250m |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from NHS England
FAQs about this procurement
Who is the buyer for "Bleeding Disorders including Haemophilia B"?
Bleeding Disorders including Haemophilia B is a UK public-sector procurement published by NHS England via Contracts Finder.
Has "Bleeding Disorders including Haemophilia B" been awarded?
Yes — 16 awards are recorded, with a reported total value of £500,000,000. The current lifecycle stage is "Award".
Which suppliers are involved in "Bleeding Disorders including Haemophilia B"?
8 suppliers are linked: Pfizer Ltd, Octapharma Limited, CSL Behring UK Ltd, Novo Nordisk, Bio Products Laboratory Ltd, Takeda UK Ltd, Sobi (Swedish Orphan Biovitrum Ltd), LFB.
What is "Bleeding Disorders including Haemophilia B" worth?
The reported award value is £500,000,000.
When was "Bleeding Disorders including Haemophilia B" published?
It was first published on 5 Jul 2022 and last updated on 20 Jul 2022, across 2 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable